| Mar'20 | Mar'19 | Mar'18 | Mar'17 | Dec'15 | Dec'14 | Nov'14 | Nov'13 | Nov'12 | Aug'12 |
|---|---|---|---|---|---|---|---|---|---|
Net loss | |||||||||
- | - | - | - | -11,726 | - | -53 | -56 | -27 | -26 |
Cash flows from operating activities: | |||||||||
Net loss | |||||||||
-22,000 | -32,983 | -18,969 | -15,206 | - | -2,660 | - | - | - | - |
Adjustments to reconcile net loss to net cash used in operating activities: | |||||||||
Depreciation | |||||||||
5 | 8 | 4 | 4 | 4 | 4 | - | - | - | - |
Issuance of common stock for services | |||||||||
- | - | - | 350 | 825 | 0 | - | - | - | - |
Stock-based compensation and stock issued to Scientific Advisory Board members | |||||||||
- | - | - | 0 | 325 | 0 | - | - | - | - |
Amortization of employees, directors and consultants stock options | |||||||||
6,085 | 8,563 | 7,689 | 7,721 | 485 | 0 | - | - | - | - |
Warrant modification expense | |||||||||
- | 1,289 | - | - | - | - | - | - | - | - |
Severance stock based compensation | |||||||||
- | 388 | - | - | - | - | - | - | - | - |
Change in fair value of warrant liability | |||||||||
-3,644 | - | - | - | - | - | - | - | - | - |
Inducement for conversion of Bridge Note to common shares | |||||||||
- | - | - | 0 | 3,465 | 0 | - | - | - | - |
Gain on remeasurement of derivative liability | |||||||||
- | - | 390 | 0 | 376 | 0 | - | - | - | - |
Loss on disposal of fixed assets | |||||||||
- | - | - | 0 | - | -2 | - | - | - | - |
Change in operating assets and liabilities: | |||||||||
Prepaid rent | |||||||||
- | 337 | 6 | - | - | - | - | - | - | - |
Prepaid clinical costs | |||||||||
-195 | 442 | 1,415 | - | - | - | - | - | - | - |
Prepaid expenses and other assets | |||||||||
-538 | -433 | -91 | 2 | -109 | 30 | - | - | - | - |
Operating lease right-of-use asset | |||||||||
-297 | - | - | - | - | - | - | - | - | - |
Accounts payable and other current liabilities | |||||||||
-865 | 654 | -131 | 1,271 | 278 | 1,168 | -3 | 9 | 0 | 0 |
Severance payable | |||||||||
-428 | 2,063 | - | - | - | - | - | - | - | - |
Accrued bonuses | |||||||||
305 | 246 | 1,248 | - | - | - | - | - | - | - |
Operating lease liability | |||||||||
-49 | - | - | - | - | - | - | - | - | - |
Net cash used in operating expenses | |||||||||
- | - | - | -5,861 | - | -1,515 | - | - | - | - |
Net cash used in operating activities | |||||||||
-19,560 | -20,116 | -11,879 | - | -6,610 | - | -57 | -47 | -27 | -26 |
Cash flows from investing activities: | |||||||||
Purchase of property & equipment | |||||||||
- | 15 | - | 0 | - | 2 | - | - | - | - |
Net cash used in investing activities | |||||||||
- | -15 | - | - | - | - | - | - | - | - |
Cash flows from financing activities: | |||||||||
Net cash used in investing activities | |||||||||
- | - | - | 0 | - | -2 | - | - | - | - |
Insurance note payments | |||||||||
597 | 480 | - | 232 | - | 0 | - | - | - | - |
Proceeds from registered offerings, net of issuance costs | |||||||||
32,555 | 5,668 | - | - | - | - | - | - | - | - |
Capital contributions - non-controlling interest | |||||||||
- | - | - | 0 | - | 35 | - | - | - | - |
Repayment from stockholders/members | |||||||||
- | - | - | 0 | -355 | 149 | - | - | - | - |
Change in due to officer | |||||||||
- | - | - | 0 | - | 0 | - | - | - | - |
Proceeds from Bridge Note | |||||||||
- | - | - | 0 | 960 | 1,350 | - | - | - | - |
Proceeds from private placement offering of common stock and warrants, net of issuance costs | |||||||||
- | - | 2,597 | 10,470 | 7,230 | 0 | - | - | - | - |
Proceeds from issuance of convertible notes | |||||||||
- | - | - | 0 | - | 200 | - | - | - | - |
Proceeds from the collection of stock subscription receivable | |||||||||
- | - | 174 | 0 | 2,500 | 0 | - | - | - | - |
Proceeds from registered offerings, net of issuance costs | |||||||||
- | - | 21,740 | - | - | - | - | - | - | - |
Shareholder advances | |||||||||
- | - | - | - | - | - | 57 | 31 | 0 | - |
Issuance of common stock from at-the-market financing facility (net of expenses) | |||||||||
- | - | 5,824 | - | - | - | - | - | 34 | 43 |
Proceeds from exercise of stock options | |||||||||
- | 270 | 35 | - | - | - | - | - | - | - |
Net cash provided by financing activities | |||||||||
- | - | - | 10,238 | - | 1,435 | - | - | - | - |
Net cash provided by financing activities | |||||||||
31,958 | 5,458 | 30,372 | - | 11,046 | - | 57 | 31 | 34 | 43 |
Net increase (decrease) in cash | |||||||||
12,398 | -14,673 | - | - | - | - | - | - | - | - |
Net increase (decrease) in cash and cash equivalents | |||||||||
- | - | 18,492 | 4,377 | 4,436 | -82 | - | -15 | 7 | 17 |
Supplemental Cash Flow Information: | |||||||||
Cash paid for interest and income taxes are as follows: | |||||||||
Interest | |||||||||
114 | 7 | - | - | - | - | - | - | - | - |
Interest | |||||||||
- | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Income taxes | |||||||||
- | - | - | 0 | 0 | 0 | - | - | - | - |
Noncash investing and financing activities: | |||||||||
Financing of insurance premiums | |||||||||
518 | 597 | 480 | 0 | - | 0 | - | - | - | - |
Deferred expenses related to post year end financing | |||||||||
- | 220 | - | - | - | - | - | - | - | - |
Conversion of the Bridge Note and all accrued interest into shares of common stock | |||||||||
- | - | - | 0 | 2,404 | 0 | - | - | - | - |
Subscribed and subscription receivable shares in conjunction with private placement offering | |||||||||
- | - | - | 174 | 2,500 | 0 | - | - | - | - |
Inducement for conversion of Bridge Note to common shares | |||||||||
- | - | - | 0 | 3,465 | 0 | - | - | - | - |
Derivative liability associated with the price protection feature of shares of common stock issued | |||||||||
- | - | 11 | 378 | 376 | 0 | - | - | - | - |
Retirement and cancellation of shares of common stock | |||||||||
- | - | 0 | - | - | - | - | - | - | - |
Conversion of $1.126 million of convertible debt into 3,624,400 shares of common stock; simultaneously, stockholders surrendered an equal amount of their own common stock, thereby having no change in the total number of shares outstanding | |||||||||
- | - | - | 0 | - | 1,152 | - | - | - | - |
Luminant member advances assigned in buyout of noncontrolling interest | |||||||||
- | - | - | 0 | - | 1,100 | - | - | - | - |
Contribution of noncontrolling interests by stockholders of Tyme Inc. | |||||||||
- | - | - | 0 | - | 2,000 | - | - | - | - |
Cash paid for income taxes | |||||||||
- | - | - | - | - | - | 0 | 0 | 0 | 0 |